Close Menu

NEW YORK, Jan 25 – Structural Bioinformatics said Thursday that it had reached a deal to “elucidate” protein structures for The RW Johnson Pharmaceutical Research Institute, a subsidiary of Johnson & Johnson.

“We are extremely pleased to begin a relationship with The R.W. Johnson
Pharmaceutical Research Institute on target structure elucidation,” Edward Maggio, CEO of SBI, said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.